Table 2. Treatments.
Patient | Country | Treatment number | Bleomycin (IE) | Pulses (n) | Highest current (A) | Treated tumor surface | Treatment duration (min) | Comment to treatment | Treatment outcome | |
1 | Ireland | 1 | 31,500 | IV | 9 | 7 | > 50 % | 80 | Partial response | |
2 | 31,500 | IV | 12 | 11 | ~ 100 % | 18 | Complete response | |||
2 | Ireland | 1 | 20,000 | IV | 17 | 16 | > 25 % | 25 | Partial response | |
2 | 20,000 | IV | 31 | ~ 100 % | 39 | Complete response | ||||
3 | Ireland | 1 | 15,000 | IV | 8 | 4 | > 75 % | 22 | Voltage decreased to 650 V due to discomfort from muscular contractions. | Partial response |
4 | Ireland | 1 | 25,000 5,000 | IV IT | 11 | 16 | > 25 % | 32 | Partial response | |
5 | Denmark | 1 | 27,450 | IV | 34 | 13 | > 25 % | 62 | Partial response | |
6 | Denmark | 1 | 27,000 | IV | 7 | 21 | > 50 % | 48 | Voltage decreased to 900 V due to lack of capacity of the cliniporator. | Partial response |
2 | 27,000 | IV | 18 | 21 | > 75 % | 24 | Voltage decreased to 900 V due to lack of capacity of the cliniporator. | Partial response | ||
7 | Denmark | 1 | 30,000 | IV | 16 | 21 | ~ 100 % | 31 | Complete response | |
2 | 30,000 | IV | 15 | 21 | > 75 % | 49 |
IV, intravenous; IT, intratumoral